Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1401 - 1422 of 1422

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1501 - 1525 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
CADTH Pharmaceutical Reviews Update — Issue 3		Oct 11, 2018	Reimbursement Review	Pharmaceutical Review Update
Canagliflozin and metformin hydrochloride	cdr_SR0480_TBC.pdf SR0480_complete_Invokamet-Aug-29-16.pdf SR0480_Invokamet_Combination_Product_Subsmission_Report.pdf SR0480_Invokamet_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0480-000
Tesamorelin	cdr_SR0477_Egrifta.pdf SR0477_complete_Egrifta_Aug-26-16.pdf SR0477_Egrifta_CL_Report.pdf SR0477_Egrifta_PE_Report.pdf SR0477_Egrifta_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0477-000
ticagrelor	cdr_SR0474_Brilinta.pdf SR0474_complete_Brilinta-Aug-29-16.pdf SR0474_Brilinta_CL_Report.pdf SR0474_Brilinta_PE_Report.pdf SR0474_Brilinta_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0474-000
Tiotropium / olodaterol	cdr_SR0436_Inspiolto_Respimat.pdf SR0436_complete_Inspiolto-Respimat-Dec_21-15-e.pdf SR0436_Inspiolto_Respimat_CL_Report.pdf SR0436_Inspiolto_Respimat_PE_Report.pdf SR0436_Inspiolto_Respimat_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0436-000
Adalimumab	cdr_SR0450_Humira.pdf SR0450_complete_Humira-Apr-19-16_e.pdf SR0450_Humira_UC_CL_Report.pdf SR0450_Humira_UC_PE_Report.pdf SR0450_Humira_UC_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0450-000
Emtricitabine /tenofovir alafenamide	cdr_SR0470_TBC.pdf SR0470_complete_Descovy-Aug-26-16.pdf SR0470_Descovy_CL_Report.pdf SR0470_Descovy_PE_Report.pdf SR0470_Descovy_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0470-000
An Overview of Clinical Applications of Artificial Intelligence		Oct 1, 2018	Horizon Scan	Emerging Health Technologies	Completed	EH0070-000
fluticasone furoate/umeclidinium/vilanterol	SR0562_cdr_complete_Trelegy_Ellipta_Aug_27_18.pdf SR0562_TrelegyEllipta_CL_Report.pdf SR0562_TrelegyEllipta_PE_Report.pdf SR0562_TrelegyEllipta_PI_Submissions.pdf	Sep 19, 2018	Reimbursement Review		Complete	SR0562-000
eluxadoline	SR0560_cdr_complete_Viberzi_Aug_29_18.pdf SR0560_Viberzi_CL_Report.pdf SR0560_Viberzi_PE_Report.pdf SR0560_Viberzi_PI_Submissions.pdf	Sep 18, 2018	Reimbursement Review		Complete	SR0560-000
CADTH Pharmaceutical Reviews Update — Issue 2		Sep 13, 2018	Reimbursement Review	Pharmaceutical Review Update
Perampanel	SR0458 Fycompa PGTCS .pdf SR0458_complete_Fycompa_May-20-16_e.pdf SR0458_Fycompa_PGTCS_CL_Report.pdf SR0458_Fycompa_PE.pdf SR0458_Fycompa_PI_Submissions_Consolidated_validated.pdf	Sep 13, 2018	Reimbursement Review		Complete	SR0458-000
Adalimumab	SR0455 Humira HS.pdf SR0455_complete_Humira-HS_May-24-16_e.pdf SR0455_HumiraHS_CL_Report.pdf SR0455_HumiraHS_PE_Report.pdf SR0455 Humira HS - _PI_Submissions_Consolidated_validated.pdf	Sep 13, 2018	Reimbursement Review		Complete	SR0455-000
Denosumab (Drug Plan Submission)	SR0433-000 Xgeva.pdf SR0433-000_complete_Xgeva_BC-Mar_1_16_e.pdf SR0433_000_XgevaBC_CL_Report.pdf SR0433_000_XgevaBC_PE_Report.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0433-000
Tolvaptan	SR0435 Jinarc.pdf SR0435_complete_Jinarc-Feb_26_16_e.pdf SR0435_Jinarc_CL_Report.pdf SR0435_Jinarc_PE_Report.pdf SR0435 Jinarc Template_PI_Submissions.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0435-000
Peginterferon beta-1a	SR0440 Plegridy.pdf SR0440_complete_Plegridy-Dec-21-15_e.pdf SR0440_Plegridy_CL_Report.pdf SR0440_Plegridy_PE_Report.pdf SR0440_Plegridy Patient Input Submission.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0440-000
Certolizumab pegol	SR0394 Cimzia PsA.PDF cdr_complete_SR0394_Cimzia-PsA_Apr-21-15.pdf SR0394_CimziaPsA_CL_Report.pdf SR0394_CimziaPsA_PE_Report.pdf SR0394 Cimzia PsA_PI_Submissions.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0394-000
abobotulinumtoxinA	SR0556_Dysport_Therapeutic_Aug_23_18.pdf SR0556_Dysport_Therapeutic_CL_Report.pdf SR0556_Dysport_Therapeutic_PE_Report.pdf SR0556_Dysport_PI_Submissions.pdf	Aug 31, 2018	Reimbursement Review		Complete	SR0556-000
ixekizumab	SR0558_Taltz_PsA_Aug_23_18.pdf SR0558_TaltzPsA_CL_Report.pdf SR0558_TaltzPsA_PE_Report.pdf SR0558_TaltzPsA_PI_Submissions.pdf	Aug 31, 2018	Reimbursement Review		Complete	SR0558-000
nitisinone	SR0554_Nitisinone_Aug_23_18.pdf SR0554_Nitisinone_CL_Report.pdf SR0554_Nitisinone_PE_Report.pdf SR0554_Nitisinone_PI_Submissions.pdf	Aug 31, 2018	Reimbursement Review		Complete	SR0554-000
Alecensaro for Non-Small Cell Lung Cancer (first line) – Details	pcodr_provfund_alectinib_alecensaro_nsclc_1ln.pdf pcodr_alectinib_alecensaro_nsclc_1stln_fn_rec.pdf pcodr_alectinib_alecensaro_nsclc_1stln_fn_cgr.pdf pcodr_alectinib_alecensaro_nsclc_1stln_fn_egr.pdf pcodr_alectinib_alecensaro_nsclc_1stln_in_rec.pdf pcodr_alectinib_alecensaro_nsclc_1stln_pagfdk.pdf pcodr_alectinib_alecensaro_nsclc_1stln_fdk_hlr.pdf pcodr_alectinib_alecensaro_nsclc_1stln_clnfdk.pdf pcodr_alectinib_alecensaro_nsclc_1stln_coi_pt.pdf pcodr_alectinib_alecensaro_nsclc_1stln_coi_cln.pdf	Aug 13, 2018	Reimbursement Review		Complete	PC0125-000
CADTH Pharmaceutical Reviews Update — Issue 1		Aug 9, 2018	Reimbursement Review	Pharmaceutical Review Update
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide	SR0552_cdr_complete_Symtuza_July_27_18.pdf SR0552_Symtuza_Combined_Report.pdf SR0552_Symtuza_PI_Submissions.pdf	Aug 8, 2018	Reimbursement Review		Complete	SR0552-000
Lonsurf for Metastatic Colorectal Cancer – Details	pcodr_provfund_trifluridine_tipiracil_lonsurf_mcrc.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_fn_rec.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_fn_cgr.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_fn_egr.pdf pcodr_trifluridine-tipiracil_Lonsurf_mCRC_in_rec.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_pagfdk.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_fdk_taiho.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_ptfdk.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_clnfdk.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_coi_pt.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_coi_cln.pdf	Jul 23, 2018	Reimbursement Review		Complete	PC0122-000
Besponsa for Acute Lymphoblastic Leukemia – Details	pcodr_provfund_inotuzumab-ozogamicin_besponsa_all.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_fn_rec.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_fn_cgr.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_fn_egr.pdf pcodr_inotuzumab_besponsa_ALL_in_rec.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_pagfdk.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_fdk_pfizer.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_clnfdk.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_coi_pt.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_coi_cln.pdf	Jul 23, 2018	Reimbursement Review		Complete	PC0121-000